Statistics for Etanercept in the treatment of ankylosing spondylitis and nephrotic syndrome in the context of AA amyloidosis: a 48-month follow-up
Total visits
| views | |
|---|---|
| Etanercept in the treatment of ankylosing spondylitis and nephrotic syndrome in the context of AA amyloidosis: a 48-month follow-up | 38 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
File Visits
| views | |
|---|---|
| n e f r o l o g i a 2 0 2 1 .pdf | 77 |
Top country views
| views | |
|---|---|
| Portugal | 9 |
| United States | 9 |
| Poland | 3 |
| Brazil | 2 |
| United Kingdom | 2 |
| Colombia | 1 |
| Germany | 1 |
| Ecuador | 1 |
| Egypt | 1 |
| Indonesia | 1 |
| India | 1 |
| South Korea | 1 |
| New Zealand | 1 |
| Palestinian Territories | 1 |
| Paraguay | 1 |
| Saudi Arabia | 1 |
| Turkey | 1 |
| South Africa | 1 |